224 related articles for article (PubMed ID: 15895461)
1. TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels.
Laws SM; Perneczky R; Wagenpfeil S; Müller U; Förstl H; Martins RN; Kurz A; Riemenschneider M
Hum Mutat; 2005 Jul; 26(1):29-35. PubMed ID: 15895461
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
3. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
4. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
[TBL] [Abstract][Full Text] [Related]
5. Influence of SORL1 gene variants: association with CSF amyloid-beta products in probable Alzheimer's disease.
Kölsch H; Jessen F; Wiltfang J; Lewczuk P; Dichgans M; Kornhuber J; Frölich L; Heuser I; Peters O; Schulz JB; Schwab SG; Maier W
Neurosci Lett; 2008 Jul; 440(1):68-71. PubMed ID: 18541377
[TBL] [Abstract][Full Text] [Related]
6. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.
Fagan AM; Younkin LH; Morris JC; Fryer JD; Cole TG; Younkin SG; Holtzman DM
Ann Neurol; 2000 Aug; 48(2):201-10. PubMed ID: 10939571
[TBL] [Abstract][Full Text] [Related]
7. Study on the association between SOAT1 polymorphisms, Alzheimer's disease risk and the level of CSF biomarkers.
Lamsa R; Helisalmi S; Herukka SK; Tapiola T; Pirttila T; Vepsalainen S; Hiltunen M; Soininen H
Dement Geriatr Cogn Disord; 2007; 24(2):146-50. PubMed ID: 17622762
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease.
Wang B; Zhou S; Yang Z; Xie YC; Wang J; Zhang P; Lv Z; Zheng C; Ma X
J Neurol Sci; 2008 Jul; 270(1-2):148-51. PubMed ID: 18396294
[TBL] [Abstract][Full Text] [Related]
9. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
[TBL] [Abstract][Full Text] [Related]
10. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
[TBL] [Abstract][Full Text] [Related]
11. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms.
Zappia M; Manna I; Serra P; Cittadella R; Andreoli V; La Russa A; Annesi F; Spadafora P; Romeo N; Nicoletti G; Messina D; Gambardella A; Quattrone A
Arch Neurol; 2004 Mar; 61(3):341-4. PubMed ID: 15023809
[TBL] [Abstract][Full Text] [Related]
12. [The relation between alpha1-antichymotrypsin gene polymorphism and epsilon4 allele of apolipoprotein E gene in Alzheimer disease in Chinese].
Tang G; Jiang S; Gu N; Jin T; Lin S; Qian Y; Wang D; Zhang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Apr; 16(2):94-6. PubMed ID: 10194255
[TBL] [Abstract][Full Text] [Related]
13. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele.
Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A
Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women.
Pirskanen M; Hiltunen M; Mannermaa A; Helisalmi S; Lehtovirta M; Hänninen T; Soininen H
Eur J Hum Genet; 2005 Sep; 13(9):1000-6. PubMed ID: 15944651
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
Arosio B; Trabattoni D; Galimberti L; Bucciarelli P; Fasano F; Calabresi C; Cazzullo CL; Vergani C; Annoni G; Clerici M
Neurobiol Aging; 2004 Sep; 25(8):1009-15. PubMed ID: 15212825
[TBL] [Abstract][Full Text] [Related]
16. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.
Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196
[TBL] [Abstract][Full Text] [Related]
17. No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease.
Engelborghs S; Sleegers K; Cras P; Brouwers N; Serneels S; De Leenheir E; Martin JJ; Vanmechelen E; Van Broeckhoven C; De Deyn PP
Brain; 2007 Sep; 130(Pt 9):2320-6. PubMed ID: 17586559
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
[TBL] [Abstract][Full Text] [Related]
19. Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease.
Mariani E; Seripa D; Ingegni T; Nocentini G; Mangialasche F; Ercolani S; Cherubini A; Metastasio A; Pilotto A; Senin U; Mecocci P
J Neurol Sci; 2006 Sep; 247(2):187-91. PubMed ID: 16784755
[TBL] [Abstract][Full Text] [Related]
20. Association of an interleukin-1beta gene polymorphism at position -511 with Alzheimer's disease.
Ehl C; Kölsch H; Ptok U; Jessen F; Schmitz S; Frahnert C; Schlösser R; Rao ML; Maier W; Heun R
Int J Mol Med; 2003 Feb; 11(2):235-8. PubMed ID: 12525884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
